This Article Full Text Full Text (PDF) All Versions of this Article: 24/10/1935    most recent 01.ATV.0000142358.46276.a7v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cantor, R. M. Articles by Lusis, A. J. Search for Related Content PubMed PubMed Citation Articles by Cantor, R. M. Articles by Lusis, A. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Genetics Home Reference

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1935.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Quantitative Trait Loci for Apolipoprotein B, Cholesterol, and Triglycerides in Familial Combined Hyperlipidemia Pedigrees

Rita M. Cantor; Tjerk de Bruin; Naoko Kono; Susan Napier; Atila van Nas; Hooman Allayee; Aldons J. Lusis

From the Departments of Human Genetics (R.M.C., N.K., S.N., A.v.N., H.A., A.J.L.) and Medicine (A.J.L.), David Geffen School of Medicine at UCLA, Los Angeles, Calif; and the Department of Medicine and Cardiovascular Research Institute (T.B.), Academic Hospital, Maastricht, the Netherlands.

Correspondence to Dr Rita M. Cantor, Department of Human Genetics, David Geffen School of Medicine at UCLA, 695 Charles E. Young Dr. South, Los Angeles, CA 90095-7088. E-mail rcantor{at}mednet.ucla.edu

Objective— Familial combined hyperlipidemia (FCHL) is a genetically complex lipid disorder that is diagnosed in families by combinations of increased cholesterol, triglycerides, and/or apolipoprotein B (apoB) levels in patients and their first-degree relatives. Identifying the predisposing genes promises to reveal the primary risk factors and susceptibility pathways and suggest methods of prevention and treatment. As with most genetically complex disorders, a clinical definition of disease may not be the most useful phenotype for finding the complement of predisposing genes, and the quantitative traits used to define the disorder can provide important information. This is a report of a quantitative trait loci (QTL) analysis of FCHL.

Methods and Results— A full genome scan of 377 multi-allelic markers genotyped at 10 centimorgan (cM) intervals was conducted in 150 sibling pairs from 22 nuclear families in FCHL pedigrees. These data were analyzed by 2 multipoint QTL linkage methods using the nonparametric and Haseman–Elston procedures of the Genehunter software. Using a criterion of P<0.001 by the nonparametric analysis, we found evidence of 2 apoB QTL at 1p21-31 (P<0.000009) and 17p11-q21 (P<0.000009), a total serum cholesterol QTL at 12p13 (P<0.0001), and a serum triglycerides QTL at 4p15-16 (P<0.0002). Using the criterion of P<0.03 for at least 2 traits at the same locus, additional evidence for cholesterol (P<0.01) and a triglycerides P<0.02) was observed at 17p11-21, as well as suggestive evidence for apoB (P<0.02) and triglycerides (P<0.01) at 4q34-35, and cholesterol (P<0.01) and triglycerides (P<0.02) and a binary FCHL trait (lod=1.5) at 16p12-13.

Conclusions— QTL analyses of the traits that define FCHL are effective for localizing disease-predisposing genes.

FCHL QTL were identified at 1p21-31 and 17p11-q21 for apolipoprotein B, 12p13 for total serum cholesterol, and 4p15-16 for serum triglycerides by nonparametric linkage analyses of a full genome scan of 150 sibpairs in 22 familial combined hyperlipidemia sibships. Multiple QTL were observed at 4q34-35, 16p12-13, and 17p11-q21.

Key Words: FCHL • QTL • apolipoprotein B • cholesterol • triglycerides

This article has been cited by other articles:

				S. B. Seidelmann, L. Li, G.-Q. Shen, E. J. Topol, and Q. K. Wang Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MI J. Lipid Res., May 1, 2008; 49(5): 1034 - 1038. [Abstract] [Full Text] [PDF]

				M. C. G. J. Brouwers, R. M. Cantor, N. Kono, J. l. Yoon, C. J. H. van der Kallen, M. A. L. Bilderbeek-Beckers, M. M. J. van Greevenbroek, A. J. Lusis, and T. W. A. de Bruin Heritability and genetic loci of fatty liver in familial combined hyperlipidemia J. Lipid Res., December 1, 2006; 47(12): 2799 - 2807. [Abstract] [Full Text] [PDF]

				M. C.G.J. Brouwers, N. Kono, M. M.J. van Greevenbroek, C. J.H. van der Kallen, A. J. Lusis, T. W.A. de Bruin, and R. M. Cantor Longitudinal Differences in Familial Combined Hyperlipidemia Quantitative Trait Loci. Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): e118 - e119. [Full Text] [PDF]

				R. L. Pollex and R. A. Hegele Longitudinal Differences in Familial Combined Hyperlipidemia Quantitative Trait Loci. Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): e120 - e120. [Full Text] [PDF]

				A. Malhotra, H. Coon, M. F. Feitosa, W.-D. Li, K. E. North, R. A. Price, C. Bouchard, S. C. Hunt, J. K. Wolford, and The American Diabetes Association GENNID Study Gro Meta-analysis of genome-wide linkage studies for quantitative lipid traits in African Americans Hum. Mol. Genet., December 15, 2005; 14(24): 3955 - 3962. [Abstract] [Full Text] [PDF]

				R. L. Pollex and R. A. Hegele Complex Trait Locus Linkage Mapping in Atherosclerosis: Time to Take a Step Back Before Moving Forward? Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1541 - 1544. [Full Text] [PDF]